JRSIS Health Care Corporation
JRSS · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 288.40 | -0.54 | 2.82 |
| FCF Yield | -21.47% | 3.08% | -1.05% | -0.82% |
| EV / EBITDA | 4.67 | -118,691.34 | -181.63 | -397.74 |
| Quality | ||||
| ROIC | -7.95% | 0.08% | -17.66% | -8.93% |
| Gross Margin | 18.00% | 100.00% | 12.06% | 31.15% |
| Cash Conversion Ratio | -2.85 | -3,548.31 | 1.35 | 2.62 |
| Growth | ||||
| Revenue 3-Year CAGR | 19.34% | -56.15% | -45.24% | -52.04% |
| Free Cash Flow Growth | -112.32% | 210.79% | -26.71% | -35.66% |
| Safety | ||||
| Net Debt / EBITDA | -4.16 | 1,023.73 | -7.25 | -11.25 |
| Interest Coverage | 0.00 | 0.01 | -14.89 | -7.43 |
| Efficiency | ||||
| Inventory Turnover | 0.33 | 0.01 | 0.54 | 1.03 |
| Cash Conversion Cycle | -546.80 | -14,625.69 | 425.79 | 85.95 |